Recurrent miscarriage or fetal loss syndrome ... as well as diagnostic procedures and treatment considerations.

An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix ...

Standard antibiotic treatment clears most infections ... CDI can also result in significant health complications. People with ...

FDA approved to prevent recurrent C. difficile infection (rCDI ... Home to help patients with rCDI across the U.S. receive treatment at home as well as health care settings Ferring continues ...

The primary outcome measure in PUNCH CD 3 is the proportion of patients with recurrent C. diff infection within eight weeks of starting treatment with either RBX2660 or placebo. Patients will be ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

diff to participate in a clinical trial. FMT offers hope to patients suffering from recurrent C. diff infection, as a safe and effective treatment. The majority of patients with recurrent C.

Although this treatment is relatively new it has ... NICE have found that the evidence supporting FMT for recurrent Clostridium difficile infection is sufficient for the procedure to be carried ...

Clostridium difficile infection is increasingly common with a high risk of recurrence despite antibiotic treatment. In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT ...

diff, despite a recent death. Doctors are now testing the procedure for other conditions. In 2008, gastroenterologist Colleen Kelly had a patient with a recurring and debilitating infection of the gut ...

FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is ... Ferring created REBYOTA @ Home to help patients with rCDI across the U.S. receive treatment at home as well as health ...